Correlative analysis of systemic markers from a randomized trial assessing local consolidative therapy for non-small cell lung cancer (NSCLC) patients with oligometastatic disease

被引:0
|
作者
Tang, Chad
Heymach, John V.
Reuben, Alexandre
Tran, Hai
Welsh, James
Wargo, Jennifer
Liao, Zhongxing
Tsao, Anne
Prado, Eric
Swisher, Stephen
Zhang, Jianjun
Gomez, Daniel
机构
关键词
D O I
10.1158/1538-7445.AM2017-2774
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2774
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
    Santos, Patricia Mae G.
    Li, Xingzhe
    Gomez, Daniel R.
    CANCERS, 2022, 14 (16)
  • [2] Local consolidative therapy for oligometastatic non-small cell lung cancer
    Samson, Pamela P.
    Spraker, Matthew B.
    Badiyan, Shahed N.
    Vlacich, Gregory
    Robinson, Clifford G.
    Chaudhuri, Aadel A.
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5649 - 5651
  • [4] Is local consolidative therapy adequate for the treatment of oligometastatic non-small cell lung cancer?
    Goto, Taichiro
    JOURNAL OF THORACIC DISEASE, 2019, 11 (10) : E154 - E157
  • [5] A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
    Panje, Cedric M.
    Dedes, Konstantin J.
    Matter-Walstra, Klazien
    Schwenkglenks, Matthias
    Gautschi, Oliver
    Siano, Marco
    Aebersold, Daniel M.
    Plasswilm, Ludwig
    Lupatsch, Judith E.
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 257 - 263
  • [6] Paradigm shift in local consolidative therapy for oligometastatic non-small cell lung cancer: a meta-analysis
    Cao, Christopher
    Chakos, Adam
    Guo, Allen
    Park, John J.
    Saghaie, Tajalli
    Blinman, Prunella
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [7] Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer?
    Boreta, Lauren
    Yom, Sue S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (05)
  • [8] A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer
    Panje, C. M.
    Dedes, K. J.
    Matter-Walstra, K.
    Schwenkglenks, M.
    Gautschi, O.
    Siano, M.
    Aebersold, D. M.
    Plasswilm, L.
    Lupatsch, J. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (06) : 588 - 588
  • [9] Improved Overall Survival with Local Consolidative Therapy in Oligometastatic Non-Small Cell Lung Cancer: Results from a Cohort of 194 Patients with Synchronous Disease
    Mitchell, K. G.
    Farooqi, A.
    Ludmir, E. B.
    Corsini, E. M.
    Vaporciyan, A. A.
    Swisher, S. G.
    Heymach, J.
    Zhang, J.
    Gomez, D. R.
    Antonoff, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 229 - 229
  • [10] Efficacy of local therapy for patients with oligometastatic non-small cell lung cancer
    Sato, Y.
    Fujimoto, D.
    Hosoya, K.
    Kawachi, H.
    Hamakawa, H.
    Takahashi, Y.
    Kokubo, M.
    Hara, S.
    Tomii, K.
    ANNALS OF ONCOLOGY, 2018, 29